COVID-19 Trials in Omaha, United States
Conditions / COVID-19 / Omaha, United States
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
51 total trials for this combination
Showing top 10 of 51 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | COMPLETED | PHASE2/PHASE3 |
| NCT06178991 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. | COMPLETED | PHASE3 |
| NCT05822583 | Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial | COMPLETED | PHASE4 |
| NCT05605093 | Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir) | TERMINATED | PHASE3 |
| NCT04401579 | Adaptive COVID-19 Treatment Trial 2 (ACTT-2) | COMPLETED | PHASE3 |
| NCT04955626 | To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. | COMPLETED | PHASE3 |
| NCT04426695 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | COMPLETED | PHASE1/PHASE2 |
| NCT07300839 | A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age | RECRUITING | PHASE3 |
| NCT04640168 | Adaptive COVID-19 Treatment Trial 4 (ACTT-4) | COMPLETED | PHASE3 |
| NCT05815498 | A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 | COMPLETED | — |